Corlieve Therapeutics snags seed funding

Corlieve Therapeutics, a developer of treatments for severe neurological disorders, has secured an undisclosed amount of seed financing.

Corlieve Therapeutics, a developer of treatments for severe neurological disorders, has secured an undisclosed amount of seed financing. The investors were Kurma Partners, IDinvest Partners and Pureos Bioventures.

Source: Press Release